Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies-Reference-Cited by-同舟云学术

Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies

Published:2014-09-05 Issue:19 Volume:171 Page:4425-4439
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Neveu C¹²³,Dulin F³⁴,Lefranc B²³,Galas L²³,Calbrix C²³,Bureau R³⁴,Rault S³⁴,Chuquet J¹²³,Boutin J A⁵,Guilhaudis L⁶³,Ségalas-Milazzo I⁶³,Vaudry D¹²³,Vaudry H¹²³,Santos J Sopkova-de Oliveira³⁴,Leprince J¹²³

Affiliation:

1. Inserm U982, Laboratory of Neuronal and Neuroendocrine Cell Differentiation and Communication, Neurotrophic Factors and Neuronal Differentiation Team, Institute for Research and Innovation in Biomedicine (IRIB)

2. Cell Imaging Platform of Normandy (PRIMACEN), IRIB

3. Normandie Univ; France

4. UNICAEN, CERMN-FR CNRS INC3M-SF ICORE; University of Caen; Caen France

5. Pôle d'Expertise Biotechnologie-Chimie-Biologie; Institut de Recherches Servier; Croissy-sur-Seine France

6. UMR 6014 CNRS, Analysis and Modeling Team, IRIB; University of Rouen; Mont-Saint-Aignan France

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12808/fullpdf

Reference56 articles.